As background, the Food and Drug Act in sec 503A provides that bulk drug substances that either 1) lack a USP or NF monograph, or 2) are not components of FDA-approved drug products, cannot be used in compounding unless they appear on a list created under Section 503A
Everyone responds a little differently
Body Protection Compound-157 (BPC-157) This peptide is promoted for musculoskeletal healing, though most evidence comes from animal and laboratory studies it is lacking large, high-quality human clinical trials
The cationic core corresponds to the free-base formula C10H11N2+ with a formula weight of 215.26 g/mol and CAS 1034043-18-3
This deficiency can be caused by poor dietary consumption, a breakdown in the digestive process, or from taking certain medications that make it difficult to absorb B12 (such as antacids)
Schneiders W, Reinstorf A, Pompe W, Grass R, Biewener A, Holch M, et al